FSD Pharma Inc. (NASDAQ:HUGE) went up by 11.46% from its latest closing price compared to the recent 1-year high of $14.00. The company’s stock price has collected 29.70% of gains in the last five trading sessions. Press Release reported on 12/15/20 that FSD Pharma Announces First Patient Randomized in Phase 2 Trial of FSD201 for the Treatment of Hospitalized Patients with COVID-19
Is It Worth Investing in FSD Pharma Inc. (NASDAQ :HUGE) Right Now?
Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for FSD Pharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $10.00. HUGE currently public float of 16.09M and currently shorts hold a 0.46% ratio of that float. Today, the average trading volume of HUGE was 901.21K shares.
HUGE’s Market Performance
HUGE stocks went up by 29.70% for the week, with a monthly jump of 25.15% and a quarterly performance of -20.74%, while its annual performance rate touched -69.38%. The volatility ratio for the week stands at 13.10% while the volatility levels for the past 30 days are set at 9.05% for FSD Pharma Inc.. The simple moving average for the period of the last 20 days is 23.33% for HUGE stocks with a simple moving average of -25.07% for the last 200 days.
HUGE Trading at 31.68% from the 50-Day Moving Average
After a stumble in the market that brought HUGE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.71% of loss for the given period.
Volatility was left at 9.05%, however, over the last 30 days, the volatility rate increased by 13.10%, as shares surge +22.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +35.44% upper at present.
During the last 5 trading sessions, HUGE rose by +29.70%, which changed the moving average for the period of 200-days by -40.82% in comparison to the 20-day moving average, which settled at $1.76. In addition, FSD Pharma Inc. saw 37.18% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for HUGE
Current profitability levels for the company are sitting at:
- -13869.84 for the present operating margin
- -1909.14 for the gross margin
The net margin for FSD Pharma Inc. stands at -20230.80. The total capital return value is set at -70.36, while invested capital returns managed to touch -104.65.
Based on FSD Pharma Inc. (HUGE), the company’s capital structure generated 4.38 points at debt to equity in total, while total debt to capital is 4.19. Total debt to assets is 3.68, with long-term debt to equity ratio resting at 0.30. Finally, the long-term debt to capital ratio is 0.29.
When we switch over and look at the enterprise to sales, we see a ratio of 172.50, with the company’s debt to enterprise value settled at 0.05. The receivables turnover for the company is 0.17 and the total asset turnover is 0.00. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.25.